Trifecta Capital Advisors
ABBV icon

Trifecta Capital Advisors’s AbbVie ABBV Stock Holding History

Trifecta Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$11.1M Buy
42,555
+1,250
+3% +$320K 1.38% 24
2026
Q2 		$10.4M Buy
41,305
+603
+1% +$130K 1.34% 23
2026
Q1 		$8.85M Buy
40,702
+160
+0.4% +$35.5K 1.37% 21
2025
Q4 		$9.26M Buy
40,542
+614
+2% +$140K 1.37% 23
2025
Q3 		$9.24M Buy
39,928
+900
+2% +$183K 1.41% 22
2025
Q2 		$7.24M Buy
39,028
+1,664
+4% +$309K 1.21% 29
2025
Q1 		$7.83M Buy
37,364
+907
+2% +$176K 1.64% 17
2024
Q4 		$6.48M Buy
36,457
+6,474
+22% +$1.19M 1.28% 24
2024
Q3 		$5.92M Buy
29,983
+148
+0.5% +$27.6K 1.24% 26
2024
Q2 		$5.12M Buy
29,835
+1,070
+4% +$177K 1.13% 27
2024
Q1 		$5.24M Buy
28,765
+26,480
+1,159% +$4.56M 1.28% 22
2023
Q4 		$354K Sell
2,285
-230
-9% -$33.5K 0.1% 71
2023
Q3 		$375K Sell
2,515
-29
-1% -$4.26K 0.12% 69
2023
Q2 		$343K Hold
2,544
– – 0.11% 70
2023
Q1 		$405K Buy
2,544
+29
+1% +$4.43K 0.14% 72
2022
Q4 		$406K Buy
+2,515
New +$386K 0.16% 71

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
B. Metzler seel. Sohn & Co
B. Metzler seel. Sohn & Co Frankfurt, Germany $11.5B AUM 29.17% 1-Year Est. Return

Trifecta Capital Advisors's ABBV Position: Q3 2026 in Review

Trifecta Capital Advisors increased its AbbVie (ABBV) stake by 3% in Q3 2026, buying an estimated $320K and bringing the position to 42,555 shares worth $11.1M. The position accounts for 1.38% of the portfolio, ranked #24.

Trifecta Capital Advisors first reported a position in ABBV in Q4 2022 and has held it in 16 quarters since. 1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Trifecta Capital Advisors held 42,555 shares of AbbVie worth $11.1M as of Q3 2026.
  • Trifecta Capital Advisors bought 1,250 AbbVie shares in Q3 2026, an estimated $320K.
  • AbbVie made up 1.38% of Trifecta Capital Advisors's portfolio in Q3 2026, its #24 holding.
  • Trifecta Capital Advisors first reported a position in AbbVie in Q4 2022 and has held it in 16 quarters since.
  • 1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Trifecta Capital Advisors's 13F filing for Q3 2026, filed 21 Oct 2026.